Sparfosic acid

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSparfosic acid
Drug Alias NameSparfosate sodium斯帕磷酸膦门冬酸N-phosphonacetyl- L-aspartic acidN-phosphonacetyl-L-aspartate +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAspartate carbamoyltransferase inhibitors
TargetsAspartate carbamoyltransferase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer IncMedimmune Llc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A